Cargando…
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale
BACKGROUND: Efforts to develop neuroimaging-based biomarkers in major depressive disorder (MDD), at the individual level, have been limited to date. As diagnostic criteria are currently symptom-based, MDD is conceptualized as a disorder rather than a disease with a known etiology; further, neural me...
Ejemplares similares
-
Treatment-Specific Hippocampal Subfield Volume Changes With Antidepressant Medication or Cognitive-Behavior Therapy in Treatment-Naive Depression
por: Tai, Hua-Hsin, et al.
Publicado: (2021) -
Neuroimaging-based biomarkers for treatment selection in major depressive disorder
por: Dunlop, Boadie W., et al.
Publicado: (2014) -
Neuroimaging Advances for Depression
por: Dunlop, Boadie W., et al.
Publicado: (2017) -
Cognitive behavioral therapy increases amygdala connectivity with the cognitive control network in both MDD and PTSD()
por: Shou, Haochang, et al.
Publicado: (2017) -
Why is Diagnosing MDD Challenging?
Publicado: (2016)